Skip to search formSkip to main contentSkip to account menu

pegvisomant 25 MG Injection

Known as: PEGVISOMANT 25 mg in 1 mL SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PEGVISOMANT], PEGVISOMANT PROTEIN 25MG/VIL INJ, PEGVISOMANT PROTEIN 25MG/VIL INJ [VA Product] 
National Institutes of Health

Related topics

Related topics

9 relations
AcromegalyDecreased Protein Synthesis [PE]Drug AllergyGlycine

Broader (1)

Pituitary Hormones, Anterior

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
MR-tomografisches Langzeit-Follow-up GH-produzierender Hypophysenadenome unter Pegvisomant-Therapie. Eine prospektive Studie.
In addition to previously available therapies, pegvisomant offers a new treatment of acromegaly. Therefore computer aided… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)